We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Aspira Womens Health Inc is transforming women's health with the discovery, development, and commercialization of testing options and bio-analytical solutions that help physicians assess risk, optimize patient management and improve gynecologic health outcomes for women. OVA1 plus combines its FDA-c... Aspira Womens Health Inc is transforming women's health with the discovery, development, and commercialization of testing options and bio-analytical solutions that help physicians assess risk, optimize patient management and improve gynecologic health outcomes for women. OVA1 plus combines its FDA-cleared products OVA1 and OVERA to detect the risk of ovarian malignancy in women with adnexal masses. Aspira GenetiX testing offers both targeted and more comprehensive genetic testing options with a gynecologic focus. Its focus is on delivering products that allow healthcare providers to stratify risk, facilitate early detection, and optimize treatment. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.113 | -22.3762376238 | 0.505 | 0.58 | 0.4425 | 69868 | 0.4773012 | CS |
4 | -0.398 | -50.3797468354 | 0.79 | 0.81 | 0.3821 | 98587 | 0.62287006 | CS |
12 | -0.528 | -57.3913043478 | 0.92 | 0.94 | 0.3821 | 79728 | 0.72684555 | CS |
26 | -1.013 | -72.0996441281 | 1.405 | 1.56 | 0.3821 | 88463 | 0.88786289 | CS |
52 | -4.058 | -91.191011236 | 4.45 | 5.65 | 0.3821 | 78208 | 1.38877999 | CS |
156 | -15.958 | -97.6024464832 | 16.35 | 19.35 | 0.3821 | 247113 | 8.34053389 | CS |
260 | -61.708 | -99.3687600644 | 62.1 | 158.1 | 0.3821 | 440534 | 42.50316303 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions